Sample size calculation for R-SABE [RSABE / ABEL]

posted by Lucas – Brazil, 2014-02-07 12:41 (4525 d 11:57 ago) – Posting: # 12362
Views: 21,710

Hi everybody.

ANVISA (Brazil's regulatory agency) is now studying the possibility of accepting EMA's method for scaling the BE acceptance interval based on the variability of the reference medication. So we are struggling a little bit in the sample size calculation, since it is very new to us. We have always used PASS for sample size calculation, for the standard BE studies, and did not manage to reproduce the results of PowerTOST calculations for RSABE. Is a whole different calculus? For example, when I try to calculate a sample size for a full replicate crossover design (TRTR, RTRT) considering a true ratio of 0.95, a target power of 80% and a reference ISCV of 63%, in PASS I got 28 subjects (considering the equivalence limits of 69.84%–143.19%) and in PowerTOST I got 22 subjects.
Can you guys help me with that? Should I throw away my PASS? :confused:


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
221 visitors (0 registered, 221 guests [including 22 identified bots]).
Forum time: 01:38 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5